- US12617872utility2026Heterodimeric Human Igg1 Polypeptides with Isoelectric Point Modifications0 cites
- US12559572utility2026Compositions and Methods for Treating Ige-mediated Disorders0 cites
- US12509518utility2025Methods and Compositions for Inhibiting CD32B Expressing Cells in Igg4-related Diseases0 cites
- US12497457utility2025Methods and Compositions for Inhibiting CD32B Expressing Cells in Igg4-related Diseases0 cites
- US12492253utility2025Anti-human C5 Antibodies0 cites
- US12486311utility2025Ctla4-ig Immunoadhesins0 cites
- US12466897utility2025Heterodimeric Human Igg1 Polypeptides with Isoelectric Point Modifications0 cites
- US12448423utility2025Targeted Heterodimeric Fc Fusion Proteins Containing NKG2D Antigen Binding Domains0 cites
- US12415849utility2025Heterodimeric Proteins0 cites
- US12404329utility2025Heterodimeric Antibodies That Bind Prostate Specific Membrane Antigen (PSMA) and CD30 cites
- US12398207utility2025Heterodimeric Antibodies That Bind CD3 and CLDN60 cites
- US12378326utility2025Anti-cd28 X Anti-psma Antibodies0 cites
- US12378313utility2025Bispecific Binding Agents Binding to CLDN18.2 and CD30 cites
- US12365743utility2025Anti-cd28 X Anti-psma Antibodies0 cites
- US12359002utility2025Heterodimeric Antibodies That Bind CD3 and Tumor Antigens0 cites
- US12239688utility2025IL-15/IL-15RA Heterodimeric Fc Fusion Proteins and Uses Thereof0 cites
- US12234270utility2025IL-12 Heterodimeric Fc-fusion Proteins0 cites
- US12215165utility2025Fc Variants with Altered Binding to Fcrn0 cites
- US12180302utility2024Heterodimeric Antibodies That Bind Fibroblast Activation Protein0 cites
Page 1 of 3Next →